The blood test goddess worth $4.5 billion has been cleared.
Last year, Elizabeth Holmes, co-founder and CEO of blood testing company Theranos, had a net worth of $4.5 billion and was the top-ranked Forbes list of the richest self-made women in the United States. Today, Forbes lowered her personal net worth to zero. Currently, Theronos has not commented on this matter.
Our forecast for Holmes' wealth is based entirely on a 50% stake in Theranos, which she owns. Theranos is a blood testing company founded by Holmes in 2003 to revolutionize the blood testing market. The Theranos stock is currently not traded on the open stock market, and private investors valued Itranos's stock in 2014 when it was valued at $9 billion.
Since then, Theranos has been repeatedly questioned to say that its blood test results are inaccurate, so it began to be investigated by federal agencies. In order to avoid the deterioration of the situation, Theranos has invalidated the blood test instrument "Edison" in the past two years, and issued tens of thousands of corrected medical examination reports to doctors and patients. Later, it was reported that Theronos' annual revenue was less than $100 million, all of which ultimately led Forbes to downgrade Theranos' valuation.
Forbes communicated with dozens of venture capitalists, analysts, and industry experts, and came to a new conclusion that Theranos' current valuation is only $800 million, not $9 billion. According to VC Experts, a venture capital research firm, Theranos' valuation is based on a number of patents owned by the company and $724 million in financing previously obtained. According to insiders familiar with Theranos' financial situation, Theronos' current valuation of $800 million is several times the company's current turnover.
Bright led louver fitting,Rigid and Durable Recessed Louver Fitting,Led Lighting Fixture Louver Fitting Recessed,Recessed Louver Fitting,led recessed louver fitting
Ningbo Wellway Optoelectronic Technology Co.,Ltd , https://www.wellwayopto.com